Related Experiment Video
Updated: Feb 10, 2026

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
cGMP at the centre of attention: emerging strategies for activating the cardioprotective PKG pathway
Min Park1, Peter Sandner2, Thomas Krieg3
1Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Addenbrookes Box 110, Cambridge, CB2 0QQ, UK.
Abstract:
The nitric oxide (NO)-protein kinase G (PKG) pathway has been known for some time to be an important target for cardioprotection against ischaemia/reperfusion injury and heart failure. While many approaches for reducing infarct size in patients have failed in the past, the advent of novel drugs that modulate cGMP and its downstream targets shows very promising results in recent preclinical and clinical studies. Here, we review main aspects of the NO-PKG pathway in light of recent drug development and summarise potential cardioprotective strategies in which cGMP is the main player.
Related Concept Videos
Emerging Adulthood
Introduction Cardiac Emergencies
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Applications of GIS: Disaster Management and Emergency Response
Other Glycolytic Pathways

